source
- China drafts policy to block foreign buyouts of key cell-gene therapy and siRNA platformsChina’s government has released a draft amendment to its export blacklist that would prohibit or tightly control foreign purchases of certain biopharmaceutical platforms. The rule targets propriet…
- Induced pluripotent stem cells gain momentum as new methods and clinical successes drive drug developmentInduced pluripotent stem cells (iPSCs) are moving from a research curiosity to a practical tool in drug development. After years of steady progress, recent advances are bringing iPSCs into the spot…